ALX Oncology Inc. (ALXO)

0.86

-0.10 (-10.36%)

At close: Mar 13, 2025, 3:59 PM

0.85

-0.03%

After-hours: Mar 13, 2025, 05:43 PM EDT

ALX Oncology Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-134.85M	-160.81M	-123.48M	-83.46M	-45.74M	-19.24M	-13.73M
Depreciation & Amortization	872K	836K	342K	51K	202K	429K	431K
Stock-Based Compensation	27.09M	26.27M	23.84M	13.91M	5.44M	297K	269K
Other Working Capital	-8.41M	7.84M	5.34M	-7.32M	3.99M	1.28M	110K
Other Non-Cash Items	-2.6M	-4.96M	228K	5.42M	295K	11K	2.33M
Deferred Income Tax	n/a	n/a	n/a	n/a	1.27M	n/a	n/a
Change in Working Capital	-12.43M	8.3M	9.85M	-4.03M	247K	4.26M	-159K
Operating Cash Flow	-121.91M	-130.36M	-89.22M	-68.1M	-38.29M	-14.25M	-13.19M
Capital Expenditures	-447K	-1.27M	-1.43M	-4.92M	-31K	-353K	-653K
Acquisitions	n/a	n/a	233.99K	n/a	641K	n/a	n/a
Purchase of Investments	-107.41M	-246.63M	-376.79M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	194.11M	292.56M	142.8M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-233.99K	-4.26M	641K	n/a	n/a
Investing Cash Flow	86.26M	44.66M	-235.42M	-4.92M	610K	-353K	-653K
Debt Repayment	-827K	-388K	9.61M	-281K	-6.51M	5.92M	n/a
Common Stock Repurchased	351K	n/a	336K	202K	n/a	n/a	-6K
Dividend Paid	n/a	n/a	n/a	n/a	-3K	n/a	n/a
Other Financial Acitivies	31.64M	792K	248K	2.75M	104.68M	9.44M	7K
Financial Cash Flow	30.82M	59.29M	9.86M	2.47M	462.88M	15.36M	1K
Net Cash Flow	-4.84M	-26.42M	-314.78M	-70.55M	425.2M	755K	-13.84M
Free Cash Flow	-122.36M	-131.64M	-90.65M	-73.02M	-38.32M	-14.6M	-13.84M